Navigation Links
Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Announces the Highly Anticipated Release of Medrio 8.1 with iPad Support
Date:4/23/2013

San Francisco, CA (PRWEB) April 23, 2013

Medrio, a leading EDC and eClinical SaaS provider for clinical research, announces the highly anticipated release of Medrio 8.1 with iPad support. In this release, the same powerful platform has been redesigned with a fresh new look and offers customers enhanced navigation for ease of use.

Highlights of the Medrio 8.1 with iPad support release:

  •         Most commonly used functions are more readily available
  •         New workflow-driven home screen with high-level summaries
  •         Enter and monitor data on-site with your iPad
  •         Manage your study remotely

“The new 8.1 Medrio user interface was thoughtfully designed and helps the user navigate the pages more intuitively,” said Ashleigh Wilson, Clinical Data Manager at Heartflow. “It allows me to find what I need with fewer clicks and less time spent scrolling. The addition of iPad support will help our monitors greatly in the field.”

“We are thrilled to unveil Medrio 8.1, a more user-friendly platform we’ve designed in order to make our system simpler to navigate and perform the tasks necessary to conduct clinical trials,” said Jeff Johnson, Medrio’s Director of Customer Experience. “We’ve also incorporated features to improve system performance and maintain our high level of reliability. This has been a collaborative effort and our customers are responding with a great deal of excitement about the new platform and superior usability.”

About Medrio, Inc.

Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information visit http://www.medrio.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10525701.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor
2. Antimicrobial Test Laboratories Emerges as Leading Provider of Virus Testing Services
3. Biotrial, a Successful Leading CRO, Continues to Expand its Activities, Creating a Unique Neuroscience Pool of Talent and Capabilities: Biotrial Neuroscience
4. Leading Biotoxin & Mold Illness Authority Creates Certification Process for Treatment Protocol
5. Leading Chemical Manufacturer Expands Biobased Offering through Unique Distribution of Proven Green Spill Absorbent
6. Leading Photonics and Laser Researchers to Present Latest Work at SPIE Optics + Optoelectronics
7. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
8. BioElectronics Product Cited for "Most Innovative New OTC Product" From Leading UK-based Healthcare Marketing Publication
9. Dr. Ali S. Faqi and Leading Scientists Author Ground-Breaking Toxicology Book from Elsevier
10. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
11. Mylan to Acquire Agila to Create Leading Global Injectables Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... ... ’s CEO and founder, Dr. Bob Harman DVM, MPVM, is featured in an interview with ... Tide". Dr. Harman and Dr. Riordan met in 2003 and have remained in contact ... stem cell therapy and a fast friendship was formed. , Dr. Harman has been a ...
(Date:9/19/2017)... California (PRWEB) , ... September 19, 2017 , ... ... biology technologies, today announced a partnership with Cytena GmbH to launch the CloneSelect™ ... and real-time image analysis to isolate single cells and provide visual documentation of ...
(Date:9/18/2017)... , Sept. 18, 2017   Montrium , a growing leader ... exciting new partnership with a groundbreaking non-profit research organization, Multidisciplinary ... ... psychotherapy studies for PTSD ... recently granted Breakthrough Therapy Designation to MDMA for the treatment of ...
(Date:9/14/2017)... London UK (PRWEB) , ... September 14, 2017 ... ... the most innovative minds in pharma and biotech at the third annual DrugDev ... collaborative conference that brings together the world’s most progressive clinical research leaders for ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):